Combine cytogenetics methods urged
ASI (Zytomics) advocated a multimodal cytogenetics approach—using karyotyping, FISH and genomic sequencing together—to find structural variants that sequencing alone might miss. The social post recommended combining traditional and genomic methods for complex variant detection. (x.com)
Cytogenetics labs still need microscopes as well as sequencers, because some chromosome changes are easiest to see as whole structures rather than as code. (academic.oup.com) Applied Spectral Imaging, now part of Zytomics, made that case in a recent social post while selling software for digital karyotyping and fluorescence in situ hybridization, or FISH, alongside broader cytogenetics workflows. Zytomics says the combined company is building integrated pathology and cytogenetics systems, and ASI’s cytogenetics line includes tools for both karyotyping and FISH analysis. (zytomics.com) (spectral-imaging.com) Karyotyping is the older method: lab staff stop cells while chromosomes are condensed, stain them, and arrange the full set like a sorted deck of cards to spot missing, extra, swapped or broken pieces. A 2024 review in the *Journal of Applied Laboratory Medicine* said banding methods still play “crucial roles” in clinical cytogenetic testing. (pubmed.ncbi.nlm.nih.gov) FISH is more targeted. It uses fluorescent DNA probes that stick to chosen chromosome regions, letting labs check both copy number and location, including inversions and translocations that can drive cancer or clarify ambiguous chromosome findings. (genomicseducation.hee.nhs.uk) Sequencing reads DNA letter by letter, but structural variants are larger edits — deletions, duplications, inversions, rings and translocations — and no single genome-sequencing pipeline detects all of them. A 2025 *Clinical Chemistry* review said structural-variant calling needs multiple callers and careful visualization, not one automated pass. (academic.oup.com) That gap matters in prenatal testing, rare-disease workups and cancer diagnostics, where the shape of a chromosome can change prognosis or recurrence risk. The same *Clinical Chemistry* review said chromosomal microarray analysis and karyotype remain gold standards in diagnostic prenatal testing even as genome sequencing expands. (academic.oup.com) Recent reviews have moved in the same direction. A 2025 *Genes* review said clinical cytogenetics now spans banded chromosomes, FISH, microarrays and newer tools such as optical genome mapping, with each method carrying different strengths and weaknesses. (mdpi.com) Examples keep surfacing where older methods catch what newer ones can miss. An abstract presented in 2025 on chromosomal mosaicism said karyotyping and FISH remained important for low-level mosaic changes that genomic sequencing may miss. (sciencedirect.com) The practical message from ASI’s post matches where the field has been heading: not old versus new, but layered testing that combines whole-chromosome views, targeted probes and sequencing when cases get structurally complex. A 2024 review in *Journal of Applied Laboratory Medicine* said higher-throughput methods can add resolution, while banding and FISH still hold essential roles. (academic.oup.com)
